by Angela | May 27, 2026 | Science Vol 3, Issue 2
The FDA has approved vepdegestrant (Veppanu) for adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer who have progressed after at least one line of endocrine therapy. Angela Alexander, PhD, Sr Clinical...
by Trish Vickery | May 27, 2026 | Events Vol 3, Issue 2, Science Vol 3, Issue 2
Blog by Trish Vickery On April 11, the Dana Farber IBC team held their annual patient forum; the virtual format allowed patients near and far to join. The day included informative medical presentations, followed by an expert roundtable, with a new feature – breakout...
by Alisa | Mar 1, 2026 | Advocacy, Advocacy Vol 3, Issue 1, Events, Events Vol 3, Issue 1, Science, Science Vol 3, Issue 1
Introduction: Evolution of a Paper Topic When selected as an Alamo Advocate Scholar by the Alamo Breast Cancer Foundation to attend the 2025 San Antonio Breast Cancer Symposium (SABCS), I knew I’d be writing a paper on a topic of importance to Inflammatory Breast...
by Danielle Cameron | Nov 28, 2025 | Advocacy, Advocacy Vol 2, Issue 3, Events, Events Vol 2, Issue 3, Science, Science Vol 2, Issue 3
By Danielle Cameron, IBC Network Foundation Canada This fall has been a blur. I don’t say that lightly. I mean it in the truest sense. It feels like every major conference, scientific meeting, meetup, and symposium decided to land within the same tiny window of time....
by Rachel Ford | Nov 26, 2025 | Advocacy, Advocacy Vol 2, Issue 3, Science, Science Vol 2, Issue 3, Survivorship, Survivorship Vol 2, Issue 3
By Rachel Ford, an Inflammatory Breast Cancer Survivor & Advocate Introduction Inflammatory Breast Cancer (IBC) is a rare and aggressive subtype, comprising only about 1–5% of all breast cancers in the U.S.. Yet, it claims a disproportionately high share of lives....
by Terry Arnold | May 24, 2024 | Science Volume 1, Issue 2
A common question regarding inflammatory breast cancer recurrence is “what actually are we looking for?” I often get messages or emails from ladies asking about recurrence or progression of disease and they are not really sure what to look for. That alone is a...
